Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
Go back to Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies| Danaher Corp. (NYSE: DHR) | Delayed: 207.44 -1.93 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.37 | 52 Week High | $102.79 | |||
| Open | $208.05 | 52 Week Low | $75.71 | |||
| Day High | $208.44 | P/E | 54.59 | |||
| Day Low | $206.09 | EPS | $3.80 | |||
| Volume | 2,473,839 | |||||

